News
1d
Pharmaceutical Technology on MSNArrowhead sells China hypertriglyceridemia candidate rights to SanofiA rrowhead Pharmaceuticals’ subsidiary Visirna Therapeutics has entered an asset purchase agreement with Sanofi for the ...
Apple Inc. is closing a retail store in China for the first time, marking a notable retreat in a market where the iPhone ...
A top-performing Greater China equity fund manager is sticking with his conviction call on big Chinese bank stocks listed in ...
Arrowhead Pharmaceuticals strikes a $130M+ deal with Sanofi for plozasiran in Greater China, targeting high triglyceride ...
Monks, the global, purely digital, data-driven, unitary operating brand of S4Capital plc, is proud to announce the ...
CK Hutchison signals openness to include a Chinese investor in Panama Canal ports after negotiations with BlackRock expired, ...
Skimlinks, a Taboola Company, today announces a commercial partnership with ChineseAN, a leading Affiliate Network in Greater ...
Entries in the 2025 AME Greater China Awards were evaluated across four weighted criteria: Results/Effectiveness (30%), Idea ...
ZEISS Group recently announced that Martin Fischer will officially take on the role of President and CEO of ZEISS Greater China, effective from October 1, ...
BEIJING: China’s top legislator Zhao Leji has said that China’s National People’s Congress (NPC) is willing to strengthen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results